Cytomedix Receives FDA Approval for Angel PRP System

Written by  Jaimie Oh | Thursday, 08 November 2012 19:54
Social sharing
Cytomedix has received FDA approval for its Angel concentrated platelet rich plasma system for processing a small sample of blood or a mixture of blood and bone marrow aspirate.
The Angel PRP System is intended to be used in the clinic or intraoperatively at the point-of care for the safe and rapid preparation of platelet rich plasma from a small sample of whole blood or a small mixture of blood and bone marrow. The system is designed to produce consistently high platelet yields using a fully automated process and represents a significant engineering advance in autologous whole blood and bone marrow separation.

More Articles on PRP:

Dr. Mark Galland Releases Podcast on PRP

57 Sports Medicine Practices to Know

Dr. Stephen Weber Concludes Platelet-Rich Plasma Not Beneficial in Rotator Cuff Surgery

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months